PSY51 EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGE
May 1, 2011, 00:00
10.1016/j.jval.2011.02.384
https://www.valueinhealthjournal.com/article/S1098-3015(11)00523-7/fulltext
Title :
PSY51 EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00523-7&doi=10.1016/j.jval.2011.02.384
First page :
A68
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
940